A common gastrointestinal cancer drug that crosses the blood-brain barrier showed promise in patients with aggressive ...

Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...

Blueprint Medicines Corporation BPMC reported first-quarter 2025 adjusted loss of 74 cents per share, which was wider than ...

The first part – which was approved in January – covered the use of the drug in GIST patients with a platelet-driven growth factor receptor alpha (PDGFRa) exon 18 mutation, including PDGFRA ...

The role of the platelet derived growth factor receptor alpha in inflammatory breast cancer progression- Our previous research has demonstrated a significant increase in expression of the platelet ...